ask="17.40"
ask_size="3900"
average_daily_volume="218262"
bid="12.15"
bid_size="100"
book_value="9.37"
change="+0.25"
change_from_200_day_moving_average="0.14"
change_from_50_day_moving_average="2.57"
change_from_52_week_high="-8.33"
change_From_52_week_low="4.95"
change_in_percent="+1.46%"
close="17.40"
dividend_pay_date="N/A"
dividend_per_share="N/A"
dividend_yield="N/A"
earnings_per_share="-2.87"
ebitda="-84.02M"
eps_estimate_current_year="-3.10"
eps_estimate_next_quarter="-0.94"
eps_estimate_next_year="-4.21"
ex_dividend_date="N/A"
float_shares="10413000"
high="17.55"
high_52_weeks="25.73"
last_trade_date="3/6/2017"
last_trade_price="17.40"
last_trade_size="8928"
last_trade_time="4:00pm"
low="16.60"
low_52_weeks="12.45"
market_capitalization="502.16M"
moving_average_200_day="17.26"
moving_average_50_day="14.83"
name="Atara Biotherapeutics
Inc."
notes="N/A"
one_year_target_price="25.60"
open="17.10"
pe_ratio="N/A"
peg_ratio="0.00"
percent_change_from_200_day_moving_average="+0.79%"
percent_change_from_50_day_moving_average="+17.33%"
percent_change_from_52_week_high="-32.37%"
percent_change_from_52_week_low="+39.76%"
previous_close="17.15"
price_eps_estimate_current_year="N/A"
price_eps_Estimate_next_year="N/A"
price_per_book="1.83"
price_per_sales="N/A"
revenue="N/A"
shares_outstanding="28860000"
short_ratio="16.38"
stock_exchange="NMS"
symbol="ATRA"
volume="170231"
weeks_range_52="12.45 - 25.73"
